Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

53,380 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Isocitrate dehydrogenase 2 mutations correlate with leukemic transformation and are predicted by 2-hydroxyglutarate in myelodysplastic syndromes.
Lin P, Luo Y, Zhu S, Maggio D, Yang H, Hu C, Wang J, Zhang H, Ren Y, Zhou X, Mei C, Ma L, Xu W, Ye L, Zhuang Z, Jin J, Tong H. Lin P, et al. Among authors: zhou x. J Cancer Res Clin Oncol. 2018 Jun;144(6):1037-1047. doi: 10.1007/s00432-018-2627-3. Epub 2018 Mar 16. J Cancer Res Clin Oncol. 2018. PMID: 29549529
Epigenetic priming with decitabine followed by low-dose idarubicin/cytarabine has an increased anti-leukemic effect compared to traditional chemotherapy in high-risk myeloid neoplasms.
Ye XN, Zhou XP, Wei JY, Xu GX, Li Y, Mao LP, Huang J, Ren YL, Mei C, Wang JH, Lou YJ, Ma LY, Yu WJ, Ye L, Xie LL, Luo YW, Hu C, Niu LM, Dou MH, Jin J, Tong HY. Ye XN, et al. Leuk Lymphoma. 2016;57(6):1311-8. doi: 10.3109/10428194.2015.1091931. Epub 2015 Oct 13. Leuk Lymphoma. 2016. PMID: 26372888
Decitabine priming prior to low-dose chemotherapy improves patient outcomes in myelodysplastic syndromes-RAEB: a retrospective analysis vs. chemotherapy alone.
Ye L, Ren Y, Zhou X, Mei C, Ma L, Ye X, Wei J, Xu W, Meng H, Qian W, Mai W, Lou Y, Xu G, Qian J, Lou Y, Luo Y, Xie L, Lin P, Hu C, Jin J, Tong H. Ye L, et al. Among authors: zhou x. J Cancer Res Clin Oncol. 2017 May;143(5):873-882. doi: 10.1007/s00432-016-2331-0. Epub 2017 Jan 20. J Cancer Res Clin Oncol. 2017. PMID: 28108816 Free PMC article.
The high NRF2 expression confers chemotherapy resistance partly through up-regulated DUSP1 in myelodysplastic syndromes.
Lin P, Ren Y, Yan X, Luo Y, Zhang H, Kesarwani M, Bu J, Zhan D, Zhou Y, Tang Y, Zhu S, Xu W, Zhou X, Mei C, Ma L, Ye L, Hu C, Azam M, Ding W, Jin J, Huang G, Tong H. Lin P, et al. Among authors: zhou x, zhou y. Haematologica. 2019 Mar;104(3):485-496. doi: 10.3324/haematol.2018.197749. Epub 2018 Sep 27. Haematologica. 2019. PMID: 30262569 Free PMC article.
53,380 results
You have reached the last available page of results. Please see the User Guide for more information.